Clinical Trials Browser

Terminated × Prostatic Neoplasms × deltacortene × Clear all

NCT03360721 2026-03-16

Apalutamide, Abiraterone Acetate, and Prednisone in Treating Participants With Metastatic Castration Resistant Prostate Cancer

Phase 2 Terminated

Prostatic Neoplasms

NCT01145508 2017-09-19

Docetaxel and Prednisone With or Without Vaccine Therapy in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer

Phase 2 Terminated

10 enrolled 6 charts

Prostatic Neoplasms